Modulation of toll-like receptor 8 expression by antisense oligonucleotides

Details for Australian Patent Application No. 2009279855 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar R.; Putta, Mallikarjuna; Bhagat, Lakshmi; Wang, Daqing; Yu, Dong; Agrawal, Sudhir

Agent Freehills

Pub. Number AU-A-2009279855

PCT Pub. Number WO2010/017152

Priority 61/086,017 04.08.08 US

Filing date 4 August 2009

Wipo publication date 11 February 2010

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/017152 Priority application(s): WO2010/017152

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279857-Modulation of toll-like receptor 3 expression by antisense oligonucleotides

2009279852-Ultrasonic device for cutting and coagulating with stepped output